PharmaVigilant is a SaaS company providing broader technologies to streamline the clinical trial process for biopharmaceutical companies. Its full suite of patient-based technology automates the collection, management and analysis of clinical trial data. Sponsors rely on PharmaVigilant to ease the regulatory and FDA submission and approval process and ultimately go-to market more quickly with top quality drugs. PharmaVigilant's clinical solutions and services have been used on Phase 1-4 studies in excess of 300,000 patients in over 41 countries worldwide.